Theratechnologies

TROGARZO

Manufacturer:

Theratechnologies

Trogarzo HCPCS:

J1746

HCPCS Code Descriptor:

Injection, ibalizumab-uiyk, 10 mg

Category:

J Code

Trogarzo NDCs:

62064-0122-02

Primary Type:

Anti-HIV

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Trogarzo:

TROGARZO is an Anti-HIV drug manufactured by Theratechnologies and administered via the Intravenous route of administration. The J Code: J1746 is aligned to the drug TROGARZO.

ACCESS PRICING AND MORE BY REGISTERING

J1746 Added Date:

January 1, 2019

J1746 Effective Date:

January 1, 2019

J1746 Termination Date:

HCPCS Active

Trogarzo billing and coding information can be found through Theratechnologies at the link below:
Trogarzo patient assistance information can be found through The THERA patient support program at the URL: https://www.trogarzo.com/hcp/patient-support/
TROGARZO prescribing information can be found at the link below:
Information regarding TROGARZO’s side effects can be found at MedlinePlus